Neurofilament Light Chain as Disease Biomarker in a Rodent Model of Chemotherapy Induced Peripheral Neuropathy

Experimental Neurology - United States
doi 10.1016/j.expneurol.2018.06.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

Frontiers in Neurology
Neurology
2019English

Chemotherapy-Induced Peripheral Neuropathy

JAMA Oncology
Cancer ResearchOncology
2019English

Diagnostic Accuracy of CSF Neurofilament Light Chain Protein in the Biomarker-Guided Classification System for Alzheimer's Disease

Neurochemistry International
Molecular NeuroscienceCell BiologyCellular
2017English

Nutraceuticals for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Nutraceuticals and Innovative Food Products for Healthy Living and Preventive Care
English

Role of Erythropoeitin in Prevention of Chemotherapy-Induced Peripheral Neuropathy

Pakistan Journal of Biological Sciences
AgronomyCrop Science
2010English

Concomitant Medications and Risk of Chemotherapy‐Induced Peripheral Neuropathy

Oncologist
Cancer ResearchMedicineOncology
2018English

Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2017English

Chemotherapy-Induced Peripheral Neuropathy: An Update on the Current Understanding

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

The Relationship Between Evaluation Methods for Chemotherapy-Induced Peripheral Neuropathy

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy